Axial Biotech
Latest round
- Series B
Last raised
- Mar 2007
Total raised
- $14M
Investors
- 4
About Axial Biotech
Founded in 2002 in Salt Lake City, US, Axial Biotech specializes in providing premium domain names for the biotech sector.4 million in cash.com, which caters to businesses in the biotechnology sector. This domain serves as a valuable digital asset for companies looking to establish a strong online presence. Primary end users include biotech startups, research institutions, and established pharmaceutical companies focused on increasing their visibility and accessibility in the market.com generates revenue through domain sales, with the flagship domain priced at USD 3,995.46 per month for 24 months, facilitating access for a diverse clientele, from startups to established firms.The company aims to expand its service offerings and enhance its market presence.4 million, to support these initiatives. There are no specific new geographic markets identified for expansion as of now, but the company continues to focus on North America and Europe as principal regions for growth.
Who invested in Axial Biotech
4 investors across 2 rounds
See all investors in Axial Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Axial Biotech
Who invested in Axial Biotech?
Axial Biotech has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axial Biotech raised?
Axial Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Axial Biotech last raise money?
Axial Biotech's most recent round on record is a Series B, in Mar 2007.
What does Axial Biotech do?
Founded in 2002 in Salt Lake City, US, Axial Biotech specializes in providing premium domain names for the biotech sector.
Where is Axial Biotech headquartered?
Axial Biotech is headquartered in Salt Lake City, US.
Which VCs invest in companies like Axial Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Axial Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Axial Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.